On May 3, 2023, FCM MM Holdings announced that it has filed a definitive proxy statement with Securities and Exchange Commission, urged the shareholders of the Company to vote for its board nominees Farzin Farzaneh, Dr. Scott Freeman, Vivek Jain and Alexander J. Wodka, at the 2023 annual meeting of shareholders. I addition, FCM MM Holdings urged the shareholders of the Company to vote against the Company nominees Robert Barrow, Roger Crystal, Andreas Krebs, Carol A Vallone, and supported the Company nominees Suzanne Bruhn, David Gryska, at the 2023 annual meeting of shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.45 USD | -8.75% | -8.35% | +130.87% |
05-13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
05-08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+130.87% | 666M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- FCM MM Holdings Solicits Proxies from Shareholders of Mind Medicine